LIPPS RANDALL A 4
4 · OMNICELL, INC. · Filed Mar 11, 2025
Insider Transaction Report
Form 4
OMNICELL, INC.OMCL
LIPPS RANDALL A
DirectorCHAIRMAN, PRESIDENT AND CEO
Transactions
- Award
Common Stock
2025-03-08+188,794→ 341,620 total - Tax Payment
Common Stock
2025-03-08$36.99/sh−18,571$686,941→ 323,049 total
Holdings
- 8,051(indirect: By Trust)
Common Stock
- 355,861(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Shares held in trust with Mr. Lipps' wife.
- [F2]Shares held in trust for the benefit of Mr. Lipps' children.
- [F3]Reflects performance-based restricted stock units that were previously granted on February 27, 2024, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 8, 2025 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 188,794 performance-based restricted stock units (176% of target) of which 25% vested upon the determination date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively).
- [F4]Reflects withholding of shares to cover taxes due in connection with the vesting of performance-based restricted stock units